title: [Immunological Markers in Organ Transplantation].
abstract: The immunological monitoring in organ transplantation is based mainly on the determination of laboratory parameters as surrogate markers of organ dysfunction. Structural damage, caused by alloreactivity, can only be detected by invasive biopsy of the graft, which is why inevitably rejection episodes are diagnosed at a rather progressive stage. New non-invasive specific markers that enable transplant clinicians to identify rejection episodes at an earlier stage, on the molecular level, are needed. The accurate identification of rejection episodes and the establishment of operational tolerance permit early treatment or, respectively, a controlled cessation of immunosuppression. In addition, new prognostic biological markers are expected to allow a pre-transplant risk stratification thus having an impact on organ allocation and immunosuppressive regimen. New high-throughput screening methods allow simultaneous examination of hundreds of characteristics and the generation of specific biological signatures, which might give concrete information about acute rejection, chronic dysfunction as well as operational tolerance. Even though multiple studies and a variety of publications report about important advances on this subject, almost no new biological marker has been implemented in clinical practice as yet. Nevertheless, new technologies, in particular analysis of the genome, transcriptome, proteome and metabolome will make personalised transplantation medicine possible and will further improve the long-term results and graft survival rates. This article gives a survey of the limitations and possibilities of new immunological markers in organ transplantation.
authors.affiliation: Klinik für Allgemeine, Viszeral-, Thorax-, Transplantations- und Kinderchirurgie, UKSH, Campus Kiel, Kiel, Deutschland.
authors.forename: J H
authors.initials: JH
authors.lastname: Beckmann
authors.affiliation: Klinik für Allgemeine, Viszeral-, Thorax-, Transplantations- und Kinderchirurgie, UKSH, Campus Kiel, Kiel, Deutschland.
authors.forename: N
authors.initials: N
authors.lastname: Heits
authors.affiliation: Klinik für Allgemeine, Viszeral-, Thorax-, Transplantations- und Kinderchirurgie, UKSH, Campus Kiel, Kiel, Deutschland.
authors.forename: F
authors.initials: F
authors.lastname: Braun
authors.affiliation: Klinik für Allgemeine, Viszeral-, Thorax-, Transplantations- und Kinderchirurgie, UKSH, Campus Kiel, Kiel, Deutschland.
authors.forename: T
authors.initials: T
authors.lastname: Becker
mesh_terms: D015415:Biomarkers / Q000097:blood*; D006084:Graft Rejection / Q000175:diagnosis / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D015166:Monitoring, Immunologic; D063305:Organ Dysfunction Scores; D016377:Organ Transplantation; D011183:Postoperative Complications / Q000175:diagnosis / Q000276:immunology*; D011237:Predictive Value of Tests; D055031:Primary Graft Dysfunction / Q000175:diagnosis / Q000276:immunology; D023001:Transplantation Tolerance / Q000276:immunology
chemical_list: D015415:Biomarkers